BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02453282-completion@plaintrial.com
DTSTAMP:20261029T100755Z
DTSTART;VALUE=DATE:20261231
SUMMARY:Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalu
 mab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer
  (NSCLC) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT02453282
URL:https://plaintrial.com/trial/NCT02453282
END:VEVENT
END:VCALENDAR